Company profile LXRX
Google Trends for Lexicon Pharmaceuticals -stock -company
Not enough data for reliable calculations!
There is not enough data for Lexicon Pharmaceuticals -stock -company to provide analysis
There is not enough data for Lexicon Pharmaceuticals -stock -company to provide correlation calculation
There is not enough data for Lexicon Pharmaceuticals -stock -company to provide analysis
There is not enough data for Lexicon Pharmaceuticals login to provide analysis
There is not enough data for Lexicon Pharmaceuticals login to provide correlation calculation
There is not enough data for Lexicon Pharmaceuticals login to provide analysis
There is not enough data for Lexicon Pharmaceuticals careers to provide analysis
There is not enough data for Lexicon Pharmaceuticals careers to provide correlation calculation
There is not enough data for Lexicon Pharmaceuticals careers to provide analysis
There is not enough data for Lexicon Pharmaceuticals products to provide analysis
There is not enough data for Lexicon Pharmaceuticals products to provide correlation calculation
There is not enough data for Lexicon Pharmaceuticals products to provide analysis
After 39 days of this quarter the interest is at 150.0. Based on that we can calculate that during remaining 52 days it will total up to 350.0. Sotagliflozin expected interest is significantly higher compared to previous quarter (+155.5%) and same quarter last year (+276.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 115 | 128 11.3% QoQ | 100 -21.9% QoQ | 74 -26.0% QoQ |
| 2020 | 106 -7.8% YoY 43.2% QoQ | 25 -80.5% YoY -76.4% QoQ | 29 -71.0% YoY 16.0% QoQ | 150 102.7% YoY 417.2% QoQ |
| 2021 | 181 70.8% YoY 20.7% QoQ | 69 176.0% YoY -61.9% QoQ | 92 217.2% YoY 33.3% QoQ | 119 -20.7% YoY 29.3% QoQ |
| 2022 | 72 -60.2% YoY -39.5% QoQ | 131 89.9% YoY 81.9% QoQ | 72 -21.7% YoY -45.0% QoQ | 90 -24.4% YoY 25.0% QoQ |
| 2023 | 93 29.2% YoY 3.3% QoQ | 360 174.8% YoY 287.1% QoQ | 248 244.4% YoY -31.1% QoQ | 137 52.2% YoY -44.8% QoQ |
| 2024 | 150 61.3% YoY 9.5% QoQ | - | - | - |
The average 5 years interest of Sotagliflozin was 9.74 per week. The last year interest of Sotagliflozin compared to the last 5 years has changed by 88.6%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 104.57%.
Google Trends for LX9211
Q4 -50.0% YoY, -76.5% QoQ | Q1 +147.8% YoY, +147.8% QoQ | Correlation: -0.2
After 39 days of this quarter the interest is at 80.0. Based on that we can calculate that during remaining 52 days it will total up to 187.0. LX9211 expected interest is significantly higher compared to same quarter last year (+146.1%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 33 | 140 324.2% QoQ | 79 -43.6% QoQ | 77 -2.5% QoQ |
| 2020 | 222 572.7% YoY 188.3% QoQ | 111 -20.7% YoY -50.0% QoQ | 106 34.2% YoY -4.5% QoQ | 154 100.0% YoY 45.3% QoQ |
| 2021 | 73 -67.1% YoY -52.6% QoQ | 306 175.7% YoY 319.2% QoQ | 174 64.2% YoY -43.1% QoQ | 69 -55.2% YoY -60.3% QoQ |
| 2022 | 26 -64.4% YoY -62.3% QoQ | 108 -64.7% YoY 315.4% QoQ | 54 -69.0% YoY -50.0% QoQ | 78 13.0% YoY 44.4% QoQ |
| 2023 | 76 192.3% YoY -2.6% QoQ | 76 -29.6% YoY 0.0% QoQ | 179 231.5% YoY 135.5% QoQ | 149 91.0% YoY -16.8% QoQ |
| 2024 | 80 5.3% YoY -46.3% QoQ | - | - | - |
The average 5 years interest of LX9211 was 9.08 per week. The last year interest of LX9211 compared to the last 5 years has changed by 18.61%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 33.96%.
There is not enough data for LX2761 to provide analysis
There is not enough data for LX2761 to provide correlation calculation
There is not enough data for LX2761 to provide analysis
After 34 days of this quarter the interest is at 14.0. Based on that we can calculate that during remaining 58 days it will total up to 38.0. biopharmaceutical company expected interest is significantly lower compared to previous quarter (-57.8%) and same quarter last year (-72.5%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 127 |
| 2019 | 118 -7.1% QoQ | 78 -33.9% QoQ | 153 96.2% QoQ | 205 61.4% YoY 34.0% QoQ |
| 2020 | 101 -14.4% YoY -50.7% QoQ | 226 189.7% YoY 123.8% QoQ | 71 -53.6% YoY -68.6% QoQ | 38 -81.5% YoY -46.5% QoQ |
| 2021 | 84 -16.8% YoY 121.1% QoQ | 188 -16.8% YoY 123.8% QoQ | 58 -18.3% YoY -69.1% QoQ | 87 128.9% YoY 50.0% QoQ |
| 2022 | 170 102.4% YoY 95.4% QoQ | 75 -60.1% YoY -55.9% QoQ | 134 131.0% YoY 78.7% QoQ | 138 58.6% YoY 3.0% QoQ |
| 2023 | 118 -30.6% YoY -14.5% QoQ | 54 -28.0% YoY -54.2% QoQ | 90 -32.8% YoY 66.7% QoQ | 14 -89.9% YoY -84.4% QoQ |
The average 5 years interest of biopharmaceutical company was 8.92 per week. The last year interest of biopharmaceutical company compared to the last 5 years has changed by -26.91%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -43.79%.
After 39 days of this quarter the interest is at 342.0. Based on that we can calculate that during remaining 52 days it will total up to 798.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 416 | 648 55.8% QoQ | 588 -9.3% QoQ | 608 3.4% QoQ |
| 2020 | 622 49.5% YoY 2.3% QoQ | 597 -7.9% YoY -4.0% QoQ | 567 -3.6% YoY -5.0% QoQ | 638 4.9% YoY 12.5% QoQ |
| 2021 | 689 10.8% YoY 8.0% QoQ | 716 19.9% YoY 3.9% QoQ | 646 13.9% YoY -9.8% QoQ | 634 -0.6% YoY -1.9% QoQ |
| 2022 | 849 23.2% YoY 33.9% QoQ | 750 4.7% YoY -11.7% QoQ | 678 5.0% YoY -9.6% QoQ | 715 12.8% YoY 5.5% QoQ |
| 2023 | 788 -7.2% YoY 10.2% QoQ | 758 1.1% YoY -3.8% QoQ | 715 5.5% YoY -5.7% QoQ | 833 16.5% YoY 16.5% QoQ |
| 2024 | 342 -56.6% YoY -58.9% QoQ | - | - | - |
The average 5 years interest of heart failure treatment was 52.86 per week. The last year interest of heart failure treatment compared to the last 5 years has changed by 12.81%. The interest for heart failure treatment is seasonal. The last year interest is quite higher compared to 5 years ago. It has increased by 24.28%.
After 39 days of this quarter the interest is at 240.0. Based on that we can calculate that during remaining 52 days it will total up to 560.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 468 | 633 35.3% QoQ | 645 1.9% QoQ | 834 29.3% QoQ |
| 2020 | 704 50.4% YoY -15.6% QoQ | 591 -6.6% YoY -16.1% QoQ | 543 -15.8% YoY -8.1% QoQ | 598 -28.3% YoY 10.1% QoQ |
| 2021 | 621 -11.8% YoY 3.8% QoQ | 557 -5.8% YoY -10.3% QoQ | 449 -17.3% YoY -19.4% QoQ | 516 -13.7% YoY 14.9% QoQ |
| 2022 | 737 18.7% YoY 42.8% QoQ | 720 29.3% YoY -2.3% QoQ | 468 4.2% YoY -35.0% QoQ | 708 37.2% YoY 51.3% QoQ |
| 2023 | 794 7.7% YoY 12.1% QoQ | 777 7.9% YoY -2.1% QoQ | 611 30.6% YoY -21.4% QoQ | 874 23.4% YoY 43.0% QoQ |
| 2024 | 240 -69.8% YoY -72.5% QoQ | - | - | - |
The average 5 years interest of type 1 diabetes treatment was 50.15 per week. The last year interest of type 1 diabetes treatment compared to the last 5 years has changed by 13.04%. The interest for type 1 diabetes treatment is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 2.92%.
After 39 days of this quarter the interest is at 150.0. Based on that we can calculate that during remaining 52 days it will total up to 350.0. neuropathic pain treatment expected interest is significantly higher compared to previous quarter (+46.4%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 294 | 329 11.9% QoQ | 373 13.4% QoQ | 521 39.7% QoQ |
| 2020 | 464 57.8% YoY -10.9% QoQ | 487 48.0% YoY 5.0% QoQ | 397 6.4% YoY -18.5% QoQ | 505 -3.1% YoY 27.2% QoQ |
| 2021 | 517 11.4% YoY 2.4% QoQ | 640 31.4% YoY 23.8% QoQ | 528 33.0% YoY -17.5% QoQ | 308 -39.0% YoY -41.7% QoQ |
| 2022 | 499 -3.5% YoY 62.0% QoQ | 411 -35.8% YoY -17.6% QoQ | 385 -27.1% YoY -6.3% QoQ | 552 79.2% YoY 43.4% QoQ |
| 2023 | 549 10.0% YoY -0.5% QoQ | 503 22.4% YoY -8.4% QoQ | 473 22.9% YoY -6.0% QoQ | 239 -56.7% YoY -49.5% QoQ |
| 2024 | 150 -72.7% YoY -37.2% QoQ | - | - | - |
The average 5 years interest of neuropathic pain treatment was 34.96 per week. The last year interest of neuropathic pain treatment compared to the last 5 years has changed by -8.35%. The interest for neuropathic pain treatment is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 3.92%.
After 39 days of this quarter the interest is at 22.0. Based on that we can calculate that during remaining 52 days it will total up to 51.0. gastrointestinal tract treatment expected interest is significantly lower compared to previous quarter (-70.7%) and same quarter last year (-57.5%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 52 | 142 173.1% QoQ | 80 -43.7% QoQ | 32 -60.0% QoQ |
| 2020 | 37 -28.8% YoY 15.6% QoQ | 70 -50.7% YoY 89.2% QoQ | 253 216.2% YoY 261.4% QoQ | 144 350.0% YoY -43.1% QoQ |
| 2021 | 269 627.0% YoY 86.8% QoQ | 65 -7.1% YoY -75.8% QoQ | 193 -23.7% YoY 196.9% QoQ | 125 -13.2% YoY -35.2% QoQ |
| 2022 | 189 -29.7% YoY 51.2% QoQ | 242 272.3% YoY 28.0% QoQ | 143 -25.9% YoY -40.9% QoQ | 185 48.0% YoY 29.4% QoQ |
| 2023 | 120 -36.5% YoY -35.1% QoQ | 140 -42.1% YoY 16.7% QoQ | 117 -18.2% YoY -16.4% QoQ | 174 -5.9% YoY 48.7% QoQ |
| 2024 | 22 -81.7% YoY -87.4% QoQ | - | - | - |
The average 5 years interest of gastrointestinal tract treatment was 10.7 per week. The last year interest of gastrointestinal tract treatment compared to the last 5 years has changed by -5.42%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 61.92%.